Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016.
about
A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains.More on the thrombocytopenia of the non-alcoholic fatty liver disease.Metformin and Diammonium Glycyrrhizinate Enteric-Coated Capsule versus Metformin Alone versus Diammonium Glycyrrhizinate Enteric-Coated Capsule Alone in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus.The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance from the American Association for the Study of Liver Diseases.Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver Disease.Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.The Clinical Significance of GP73 in Immunologically Mediated Chronic Liver Diseases: Experimental Data and Literature Review.A simple in silico strategy identifies candidate biomarkers for the diagnosis of liver fibrosis in morbidly obese subjects.Efficacy of Acetylshikonin in Preventing Obesity and Hepatic Steatosis in db/db Mice.Non-alcoholic fatty liver disease: controlling an emerging epidemic, challenges, and future directions.Non-alcoholic fatty liver diseaseCurrent guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysisRecommendations for the management of non-alcoholic fatty liver disease (NAFLD)
P2860
Q31171499-3098BDB8-530B-4BC8-8448-8107101D88E2Q33437618-6B7FD718-9FF2-4F53-B0D1-126EA6910472Q37590804-32A15C9B-7344-4ED5-939E-EE98412F018AQ38676257-480BAE78-74EA-47ED-873C-F72517A02B62Q41706840-23B59ADB-F19D-49C2-BBF7-9783AE8B5979Q47136445-B107F1A9-3DE2-472B-8523-48D1CB0A9EC1Q47278009-BC5756AB-74B6-4CED-B1B3-4E600ADB93D1Q48222622-A099AA79-CF34-419F-82DC-7B18CAF0B32FQ51599856-C72F342C-CFE1-461F-93B3-C83F8319592FQ55315481-A77E613A-47E3-47D7-ADB8-94A9BE3BEF12Q56003593-8A47525E-67A4-4C5B-B93E-CC1EDE9730E6Q56343202-DD492694-5821-44FE-A217-A5347CB5ED56Q57494353-50B0D836-B683-4EF0-8C30-CE23EDB2860D
P2860
Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016.
@en
type
label
Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016.
@en
prefLabel
Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016.
@en
P2860
P1476
Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016.
@en
P2093
Dharmesh H Kaswala
Michelle Lai
P2860
P2888
P304
P356
10.1007/S10620-016-4079-4
P50
P577
2016-03-26T00:00:00Z
P6179
1033663836